Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

BARDA contract supports Platelet BioGenesis' development of donor-independent platelets

Oct. 8, 2019

Phase I study of CSL-200 gene therapy in adults with severe sickle cell disease

Oct. 3, 2019

Neurotransmitter receptor stimulates early blood cell progenitors

Oct. 2, 2019

Japanese approval for Evrenzo for anemia associated with chronic kidney disease in dialysis patients

Sep. 20, 2019

Inflammation stress induces red blood cell formation

Sep. 18, 2019

Edoxaban in atrial fibrillation patients after PCI: Results from ENTRUST-AF PCI

Sep. 17, 2019

Pharvaris announces financing to advance clinical development of HAE oral therapy

Sep. 13, 2019

First safety data presented from phase II trial of revacept

Sep. 5, 2019

Discovery of novel R-PTP-sigma inhibitors to promote hematopoietic stem cell regeneration

Sep. 5, 2019

Anhui New Star Pharmaceutical Development discovers P2Y12 antagonists

Aug. 26, 2019

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...